Modified erythropoietin polypeptides and uses thereof for treatment
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 28, 2012
Issued Date -
N/A
app pub date -
Nov 28, 2007
filing date -
Nov 28, 2006
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Modified erythropoietin (EPO) polypeptides and other modified therapeutic polypeptides are provided. The EPO polypeptides and other therapeutic polypeptides are modified to exhibit physical properties and activities that differ from the unmodified EPO polypeptides and other unmodified therapeutic polypeptides, respectively. Nucleic acid molecules encoding these polypeptides also are provided. Also provided are methods of treatment and diagnosis using the polypeptides.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully